Skip to main content

Berger David B's Form 4 filing

Tandem Diabetes Care Inc (TNDM) · filed Jun 10, 2022

Accession no.
0001438133-22-000159
Filed
Jun 10, 2022
Trade date
Jun 8, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $656.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Berger David BCIK 0001422126Officer (EVP & Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 8, 2022Common StockMOption exerciseAcquired+7,000$18.86+$132,02012,554Direct
Jun 8, 2022Common StockSSaleDisposed−7,000$65.03−$455,2105,554Direct
Jun 8, 2022Common StockSSaleDisposed−3,097$65.00−$201,3052,457Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 8, 2022Common StockMOption exerciseAcquired+7,000$18.86+$132,02035,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)